双健康战略
Search documents
扬子江药业集团董事长徐浩宇在首届江苏品牌建设大会发表主题演讲
Sou Hu Cai Jing· 2025-09-10 08:31
Core Viewpoint - The Jiangsu Brand Construction Conference emphasizes the importance of brand development for Jiangsu enterprises, with a focus on creating globally influential brands, particularly in the pharmaceutical and health sectors [1][3]. Group 1: Brand Development Strategy - The conference theme "Brand Strong Nation, Su Products First" reflects a collective vision for Jiangsu brands to reach a global audience [3]. - Xu Haoyu, representing Yangtze River Pharmaceutical Group, highlighted the company's brand philosophy, which is closely tied to its mission of "seeking progress and protecting lives" [3][5]. - The company prioritizes quality as the cornerstone of brand building, evidenced by its achievements in quality management and international awards [5]. Group 2: Innovation and Market Strategy - Continuous innovation is essential for meeting the growing health demands of the public, alongside maintaining high quality standards [5]. - In 2024, the company introduced a "Health Marketing, Marketing Health" dual strategy, launching health products that align with modern lifestyles [5]. - The company plans to refresh its brand with new products targeting younger demographics, such as "Little Blue Qing Oral Liquid" and "Little Blue Throat Candy" [5][6]. Group 3: Corporate Responsibility and Community Engagement - Xu emphasized that a strong brand is rooted in responsible corporate behavior, which includes providing safe and effective products and engaging in community welfare [8]. - The company has contributed over 1 billion yuan in various charitable efforts and established 80 standardized planting bases to ensure product quality and support local farmers [8]. - The call for collaboration among Jiangsu enterprises aims to enhance the "Su Products" brand and elevate it from regional strength to global recognition [8]. Group 4: Quality and Innovation as Growth Drivers - The conference highlighted the need for Jiangsu to focus on quality, innovation, ecology, culture, and openness to build strong brands that represent Chinese standards [8]. - The establishment of benchmark brands like Yangtze River Pharmaceutical is seen as crucial for contributing to a brand-strong and quality-strong nation [8].
又获国字号殊荣,扬子江药业锚定世界一流医药健康企业
Xin Hua Ri Bao· 2025-08-04 23:26
Core Points - The sixth National Excellent Builders of Socialism with Chinese Characteristics award ceremony was held, with Xu Haoyu, Chairman and President of Yangtze River Pharmaceutical Group, among the 100 honorees [1] - The selection was organized by multiple government departments to inspire non-public economic figures to contribute to national development and health needs [1] - Yangtze River Pharmaceutical Group aims to integrate its development into national strategies and focus on high-quality growth in the pharmaceutical and health industry [1] Group 1 - Yangtze River Pharmaceutical Group's health sector and international business saw significant sales growth in the first half of the year, with increases of 365% and 237% respectively, becoming a "second growth curve" for the company [2] - The company achieved a seven-star certification in the EFQM Global Award's first phase, marking it as the only pharmaceutical enterprise in China to do so [2] - The company was recognized as one of the first excellent smart factories in the country, enhancing its status in intelligent manufacturing [2] Group 2 - Yangtze River Pharmaceutical Group has made substantial contributions to social responsibility, donating over 1 billion RMB in various charitable activities, and has received accolades for its efforts [3] - The company promotes health awareness and traditional Chinese medicine culture through its brand matrix, which includes "Yangtze River" Western medicine, "Longfengtang" Chinese medicine, and "Huyou" health products [2] - As a leader in the industry, the company fosters collaborative innovation across the supply chain and has established platforms for the health industry ecosystem [2]